{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:49:50Z","timestamp":1794091790828,"version":"4.8.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.vaccine.2012.07.055","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T02:52:09Z","timestamp":1354243929000},"page":"F12-F23","source":"Crossref","is-referenced-by-count":1374,"special_numbering":"S5","title":["Global Burden of Human Papillomavirus and Related Diseases"],"prefix":"10.1016","volume":"30","author":[{"given":"David","family":"Forman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"de Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Soerjomataram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joannie","family":"Lortet-Tieulent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Vignat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Ferlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddie","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.07.055_bib0005","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2012.07.055_bib0010","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.22241","article-title":"Variations in the age-specific curves of human papillomavirus prevalence in women worldwide","volume":"119","author":"Franceschi","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0015","doi-asserted-by":"crossref","unstructured":"Guan P, Howell-Jones R, Li N, Bruni L, de Sanjos\u00e9 S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int J Cancer 2012 Feb 9. http:\/\/dx.doi.org\/10.1002\/ijc.27485 [Epub ahead of print].","DOI":"10.1002\/ijc.27485"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2012.07.055_bib0020","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ypmed.2011.08.002","article-title":"Genital HPV infection and related lesions in men","volume":"53","author":"Anic","year":"2011","journal-title":"Prev Med"},{"issue":"5","key":"10.1016\/j.vaccine.2012.07.055_bib0025","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bjc.6600194","article-title":"Prevalence and determinants of human papillomavirus genital infection in men","volume":"86","author":"Franceschi","year":"2002","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2012.07.055_bib0030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1470-2045(12)70080-3","article-title":"Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis","volume":"13","author":"Machalek","year":"2012","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.vaccine.2012.07.055_bib0035","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/cir1012","article-title":"North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America","volume":"54","author":"Silverberg","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2012.07.055_bib0040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/OLQ.0b013e3181c94a3b","article-title":"Oral human papillomavirus in healthy individuals: a systematic review of the literature","volume":"37","author":"Kreimer","year":"2010","journal-title":"Sex Transm Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2012.07.055_bib0045","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","article-title":"Prevalence of oral HPV infection in the United States, 2009-2010","volume":"307","author":"Gillison","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0050","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"The global burden of cancers attributable to infections in the year 2008: a review and synthetic analysis","volume":"13","author":"De Martel","year":"2012","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.07.055_bib0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens--Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0060","unstructured":"Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological Agents. Lyon, France, 24 February-3 March 2009 IARC Monogr Eval Carcinog Risks Hum Vol 100B 2011. Available at: http:\/\/monographs.iarc.fr\/ENG\/Monographs\/vol100B\/index.php.(last accessed July 2012)."},{"key":"10.1016\/j.vaccine.2012.07.055_bib0065","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. [Available at: http:\/\/globocan.iarc.fr (last accessed April 2012)."},{"key":"10.1016\/j.vaccine.2012.07.055_bib0070","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0075","unstructured":"World Population Prospects: The 2008 Revision Highlights. New-York; 2009."},{"key":"10.1016\/j.vaccine.2012.07.055_bib0080","first-page":"531","article-title":"The occurrence of lung cancer in man","volume":"9","author":"Levin","year":"1953","journal-title":"Acta Unio Int Contra Cancrum"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2012.07.055_bib0085","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: The burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0090","doi-asserted-by":"crossref","unstructured":"Bray F, Ren J, Masuyer E, Ferlay J. Estimates of global cancer prevalence in 2008 for 27 sites in the adult population. Int J Cancer 2012 Jul 3. http:\/\/dx.doi.org\/10.1002\/ijc.27711. [Epub ahead of print].","DOI":"10.1002\/ijc.27711"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0095","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","article-title":"Worldwide burden of cervical cancer in 2008","volume":"22","author":"Arbyn","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0100","doi-asserted-by":"crossref","unstructured":"United Nation Development Programme. Human Development Report 2009: Overcoming barriers: Human mobility and development. New York: United Nation Development Programme, 2009.","DOI":"10.18356\/9d335cec-en"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0105","unstructured":"EUROCARE: Survival of cancer patients in Europe. Available at http:\/\/www.eurocare.it (last accessed April 2012)."},{"key":"10.1016\/j.vaccine.2012.07.055_bib0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1470-2045(09)70335-3","article-title":"Cancer survival in Africa, Asia and Central America: a population-based study","volume":"11","author":"Sankaranarayanan","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0115","unstructured":"European Cancer Observatory Cancer Screening cervix uteri. Available at: http:\/\/eu-cancer.iarc.fr\/cancer-14-display-text-561-565.html,en (last accessed July 2012)."},{"key":"10.1016\/j.vaccine.2012.07.055_bib0120","unstructured":"Ferlay J, Parkin DM, Curado MP, et al. Cancer Incidence in Five Continents, Volumes I to IX: IARC CancerBase No. 9 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available at: http:\/\/ci5.iarc.fr (last accessed July 2012)."},{"key":"10.1016\/j.vaccine.2012.07.055_bib0125","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2010 Sub (1973-2008) <Katrina\/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2010 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2011, based on the November 2010 submission."},{"key":"10.1016\/j.vaccine.2012.07.055_bib0130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1158\/1055-9965.EPI-07-2691","article-title":"International correlation between Human Papillomavirus prevalence and cervical cancer incidence","volume":"17","author":"Maucourt-Boulch","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.vaccine.2012.07.055_bib0135","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/bjc.2011.301","article-title":"Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976-2005: an age-period-cohort analysis","volume":"105","author":"Dhillon","year":"2011","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.vaccine.2012.07.055_bib0140","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","article-title":"Global cancer transitions according to the Human Development Index (2008\u20132030): a population-based study","volume":"13","author":"Bray","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0145","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ijc.24838","article-title":"Changing cancer incidence in Kampala, Uganda, 1991-2006","volume":"126","author":"Parkin","year":"2009","journal-title":"Int J Cancer"},{"issue":"S5","key":"10.1016\/j.vaccine.2012.07.055_bib0150","doi-asserted-by":"crossref","first-page":"F34","DOI":"10.1016\/j.vaccine.2012.05.070","article-title":"Human papillomavirus and disease of the upper airway: head and neck cancer and respiratory papillomatosis","volume":"30","author":"Gillison","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0155","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/jmv.22111","article-title":"Analysis of human papillomavirus genotypes and viral loads in anogenital warts","volume":"83","author":"Ball","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0160","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/517447","article-title":"Association of rare human papillomavirus types with genital premalignant and malignant lesions","volume":"178","author":"Meyer","year":"1998","journal-title":"J Infec Dis"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0165","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.37.10.3316-3322.1999","article-title":"Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients","volume":"37","author":"Brown","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/sti.2004.009431","article-title":"The interrelationship of demographic and geospatial risk factors between four common sexually transmitted diseases","volume":"81","author":"Monteiro","year":"2005","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0175","doi-asserted-by":"crossref","unstructured":"Lacey CJ, Woodhall SC, Wikstrom A, Ross J. 2012 European guideline for management of anogenital warts. JEADV 2012; Mar 12. Doi: 10.1111 (Epub ahead of print).","DOI":"10.1111\/j.1468-3083.2012.04493.x"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.07.055_bib0180","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0185","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/522863","article-title":"The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries","volume":"196","author":"Kjaer","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0190","unstructured":"Centers for Disease Control and Prevention. 2010 Sexually Transmitted Diseases Surveillance. Available at: http:\/\/www.cdc.gov\/std\/stats10\/figures\/50.htm (last accessed June 2012)."},{"key":"10.1016\/j.vaccine.2012.07.055_bib0195","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(01)06883-0","article-title":"Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours","volume":"358","author":"Johnson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0200","unstructured":"Health Protection Agency UK. Topics: Infectious Diseases HIV and STIs, Geographical data. Available at: http:\/\/www.hpa.org.uk\/webc\/HPAwebFile\/HPAweb_C\/1215589015024 (last accessed June 2012)."},{"key":"10.1016\/j.vaccine.2012.07.055_bib0205","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/OLQ.0b013e318198de8c","article-title":"Twenty year trends in the incidence and prevalence of diagnosed anogenital warts in Canada","volume":"36","author":"Kliewer","year":"2009","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0210","unstructured":"De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, et al. The burden of human papillomavirus infections and related diseases in sub-Saharan Africa. Vaccine, in press."},{"key":"10.1016\/j.vaccine.2012.07.055_bib0215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2334-11-20","article-title":"Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study","volume":"11","author":"Low","year":"2011","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0220","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1473-3099(10)70297-8","article-title":"Promising control of genital warts: but is elimination possible?","volume":"11","author":"Lacey","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","article-title":"Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data","volume":"11","author":"Donovan","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0230","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus vaccination programme","volume":"87","author":"Read","year":"2011","journal-title":"Sex Transm Inf"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0235","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2105\/AJPH.2011.300465","article-title":"Evidence of human papillomavirus effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010","volume":"102","author":"Bauer","year":"2012","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0240","unstructured":"Flagg EW, Schwartz R, Weinstock H. Prevalence of anaogenital warts among participants in private health plans in the US 2003-2009: potential impact of HPV vaccination. C4.1 2012 National STD Prevention Conference. Available at: https:\/\/cdc.confex.com\/cdc\/std2012\/webprogram\/Paper29351.html (last accessed June 2012)."},{"key":"10.1016\/j.vaccine.2012.07.055_bib0245","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10552-008-9276-9","article-title":"Systematic review of human papillomavirus prevalence in invasive penile cancer","volume":"20","author":"Backes","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0250","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0255","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/sti.2010.048421","article-title":"Genital warts and cost of care in England","volume":"87","author":"Desai","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/sti.2008.030999","article-title":"Epidemiology and costs associated with genital warts in Canada","volume":"85","author":"Marra","year":"2009","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0265","first-page":"397","article-title":"The health and economic burden of genital warts in a set of private health plans in the United States","volume":"361","author":"Insigna","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0270","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.olq.0000145851.76025.ad","article-title":"Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States","volume":"31","author":"Koshiol","year":"2004","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0275","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1185\/03007990903136378","article-title":"Assessing incidence and economic burden of genital warts with data from a US commercially insured population","volume":"25","author":"Hoy","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0280","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/sti.2009.040188","article-title":"Genital warts incidence and healthcare resource utilisation in Australia","volume":"86","author":"Pirotta","year":"2010","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0285","first-page":"107","article-title":"Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France","volume":"35","author":"Monsonego","year":"2007","journal-title":"Gynecol Obster Fertil"},{"key":"10.1016\/j.vaccine.2012.07.055_bib0290","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2296-11-39","article-title":"Trends in sexually transmitted infections in the Netherlands, combining surveillance data from general practices and sexually transmitted infection centers","volume":"11","author":"van den Broek","year":"2010","journal-title":"BMC Family Practice"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12010808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12010808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T18:32:24Z","timestamp":1643740344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12010808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":58,"alternative-id":["S0264410X12010808"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}